ArticleBMC cancer2025
Association of the American heart association's new "life's essential 8" cardiovascular health with all-cause and cardiovascular mortality in adults with and without cancer: a retrospective cohort study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe American Heart Association released an updated algorithm used to assess cardiovascular health (CVH)-the Life's Essential 8 (LE8) score. Our objective was to quantify the association between CVH levels estimated by the LE8 score and all-cause and cardiovascular mortality in adults with and without cancer.
methodsIn this retrospective cohort study, 29,352 adults were included from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 at baseline linked to the 2019 National Death Index records. Cox regression models and Restricted cubic spline were used to evaluate the associations between CVH with cardiovascular mortality and all-cause mortality.
resultsIn this study, 14.8% of adults achieved a high total CVH score, compared to 20.3% with low scores. The adjusted HR (95% CI) for all-cause mortality in adults without cancer with a moderate or high CVH total scores compared with low scores was 0.71 (0.64, 0.79) and 0.46 (0.35, 0.60), respectively. The corresponding adjusted HR (95% CI) for cardiovascular disease (CVD) mortality was 0.58 (0.47, 0.72) and 0.30 (0.16, 0.57), respectively. And all 8 CVH indicators in CVD mortality were protective factors. The adjusted HRs (95% CI) for all-cause mortality in adults with cancer with moderate or high scores were 0.73 (0.58, 0.92) and 0.75 (0.48, 1.18), respectively.
conclusionAccording to the new LE8, higher CVH scores were associated with a reduced risk of all-cause and CVD-specific mortality in adults with and without cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.